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Congenital Stationary Night Blindness in the Dog: Common Mutation in the
RPE65 Gene Indicates Founder Effect
Abstract
Purpose: To clone and characterize the canine RPE65 cDNA from normal dog, examine for mutations, and
establish if the mutation identified in Swedish briard dogs with retinal dystrophy is present in dogs of the
same breed that originated from the United States and other countries, and are affected with congenital
stationary night blindness.
Methods: Fifteen briard dogs were studied, of which 10 were affected with csnb, and five were clinically
normal. In addition, we tested samples from four Swedish dogs, and samples from a briard affected with
progressive retinal atrophy. RPE65 cDNA was cloned a from retinal cDNA library by PCR, and from canine
retina by RT-PCR. ERG and morphology were used to characterize csnb.
Results: The normal RPE65 cDNA spans 1724 nucleotides (GenBank accession number AF084537), and
includes 1602 nucleotides of coding sequence; the deduced amino acid sequence shares 98%, 97%, and
93% identity with homologous human, bovine, and rat sequences, respectively. A homozygous four
nucleotide (AAGA) deletion, representing nucleotides 487-490 of wildtype RPE65 sequence, was found
only in csnb and retinal dystrophy affected dogs; heterozygous animals had normal and mutant alleles.
The mutation produces a frameshift, causing a deduced mistranslation with a premature stop codon. The
mutation causes retinal dysfunction and RPE accumulation of lipid vacuoles.
Conclusions: Identification of the same mutation in csnb and retinal dystrophy confirms the molecular
identity of the two disorders. A common mutation in dogs derived from different countries suggests a
founder effect causing the propagation of a common mutant allele in the population at risk.
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Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect
Gustavo D. Aguirre,1 Victoria Baldwin,1 Sue Pearce-Kelling,1 Kristina Narfström,2Kunal Ray,1 Gregory M.
Acland1
1

James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA; 2Department of Medicine & Surgery, Faculty of Veterinary Medicine, Swedish University of Agricultural Sciences, Uppsala,
Sweden

Purpose: To clone and characterize the canine RPE65 cDNA from normal dog, examine for mutations, and establish if the
mutation identified in Swedish briard dogs with retinal dystrophy is present in dogs of the same breed that originated from
the United States and other countries, and are affected with congenital stationary night blindness.
Methods: Fifteen briard dogs were studied, of which 10 were affected with csnb, and five were clinically normal. In
addition, we tested samples from four Swedish dogs, and samples from a briard affected with progressive retinal atrophy.
RPE65 cDNA was cloned a from retinal cDNA library by PCR, and from canine retina by RT-PCR. ERG and morphology
were used to characterize csnb.
Results: The normal RPE65 cDNA spans 1724 nucleotides (GenBank accession number AF084537), and includes 1602
nucleotides of coding sequence; the deduced amino acid sequence shares 98%, 97%, and 93% identity with homologous
human, bovine, and rat sequences, respectively. A homozygous four nucleotide (AAGA) deletion, representing nucleotides 487-490 of wildtype RPE65 sequence, was found only in csnb and retinal dystrophy affected dogs; heterozygous
animals had normal and mutant alleles. The mutation produces a frameshift, causing a deduced mistranslation with a
premature stop codon. The mutation causes retinal dysfunction and RPE accumulation of lipid vacuoles.
Conclusions: Identification of the same mutation in csnb and retinal dystrophy confirms the molecular identity of the two
disorders. A common mutation in dogs derived from different countries suggests a founder effect causing the propagation
of a common mutant allele in the population at risk.

The briard dog is affected with a recessively inherited
retinal disorder characterized by congenital night blindness
with various degrees of visual impairment under photopic illumination. Vision in affected dogs ranges from normal day
vision to profound day blindness [1]. The disease was initially
described in Swedish dogs as a stationary disorder analogous
to human congenital stationary night blindness (CSNB [2]).
More recently, the disease has been described as having a progressive component, and has been termed hereditary retinal
dystrophy [3,4]. Along with the visual impairment, affected
dogs have an abnormal electroretinogram (ERG); in general,
the recorded responses are normal in waveform, but show a
marked diminution of response amplitudes, similar to a “Riggs
type” ERG in man. The ERG recorded under DC conditions
shows complete absence of the a-, b-, and c-waves, with the
latter waveform being replaced by a very slow negative potential which develops when the stimulus intensity is greater
than 3 log units above the normal b-wave threshold. The authors interpret the abnormalities in the a- and b-waves as representing a delay in rod phototransduction [5]. A similar disease is also recognized in other countries, including France,
Canada, and the United States. In the US, the disease is termed
Correspondence to: Gustavo D. Aguirre, James A. Baker Institute
for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853-6401, USA; Phone: (607) 256-5620; FAX:
(607) 256-5689; email: gda1@cornell.edu
Dr. Ray is now at the Indian Institute of Chemical Biology, Calcutta,
India.

congenital stationary night blindness, and csnb has been designated as the gene symbol for the disease locus. Apart from
the above studies in Swedish briard dogs, no other systematic
investigation of the disease has been reported, nor has there
been definitive proof that csnb and retinal dystrophy represent the same disorder.
During a presentation on the mutation spectrum of the
RPE65 gene in childhood onset retinal dystrophies at the 1998
ARVO meeting, Andreas Gal and associates stated that a 4nucleotide (AAGA) deletion in the RPE65 gene was responsible for hereditary retinal dystrophy in the Swedish briard
dog [6]. This presentation prompted us to clone and characterize the canine RPE65 cDNA from normal dog, examine for
mutations in the coding sequence of this gene, and establish if
the mutation described in Swedish briards is present in dogs
of the same breed that originated from the United States and
other countries. Our results indicate that the same four nucleotide deletion in the RPE65 gene is the mutation causing csnb
in the briard dog.
METHODS
Animals: Briard dogs affected with csnb and related and unrelated phenotypically normal dogs have been examined to
characterize the disease phenotype, and examine for mutations in the RPE65 gene. Overall, we have studied 15 briard
dogs, of which 10 were affected with csnb, and five were clinically normal. These dogs came primarily from the US and
Canada, of breeding stock that originated from the US and
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France. In addition, we tested samples from four Swedish dogs,
both purebred briard or briard-beagle crosses, of which two
were affected and two heterozygous for the reported four nucleotide deletion in the RPE65 gene. Lastly, we tested samples
from four littermate briard dogs that we had examined previously. One individual from this last group of four dogs was
clinically affected with a retinal degenerative disorder. This
dog, at 6 years of age, showed evidence of night blindness,
hesitant behavior in bright light, and ophthalmoscopically visible retinal thinning and vascular attenuation characteristic of
mid-stage progressive retinal atrophy (PRA [7]). ERG testing
confirmed the retinal disorder, and indicated that only cone
mediated responses were recordable (Aguirre, unpublished
data).
All dogs studied were subjected to a comprehensive clinical ophthalmic examination, including indirect ophthalmoscopy and slit lamp biomicroscopy. In addition, a selected number of dogs underwent ERG testing as previously described
[8]. Briefly, the ERG was recorded from the halothane anesthetized dog using a stimulus protocol that, by differentially
eliciting rod and cone components of the ERG, allowed their
separate evaluation [7-10]. Signal averaging of very low amplitude responses also was conducted to examine the waveform of these responses.
The eyes from two dogs, 4.3 and 10.7 months of age,
were removed following euthanasia by barbiturate overdose,
and processed for microscopic examination using methods we
have previously described for embedding either in plastic (4.3
months, both eyes) [10] or in the synthetic wax diethylene
glycol distearate (DGD; 10.7 months, one eye) [11]; the tissues were sectioned at 1 µm and stained with azure II/methylene blue. The retina of the fellow eye of the 10.7-month-old
dog was isolated under sterile conditions, and kept frozen at -

Figure 1. Electroretinographic responses in csnb. Representative dark
adapted ERG responses recorded from a normal dog (left) and two
briard dogs with csnb (center and right). The normal dog responds to
scotopically balanced red and blue light stimuli with responses which
are similar in waveform and amplitude. The response to a single high
intensity (4.0 log-foot Lamberts) white light stimulus is biphasic,
with a prominent a-wave, and an overall shorter latency b-wave response. In contrast, dogs affected with csnb have minute responses
which are barely discernible over the baseline noise. When signal
averaged over eight responses (n = 8), a distinct ERG response is
evident, and the waveform is more characteristic of the normal response in the younger (4 months, center column) than in the older (2
years, right column) animal. This difference is not a characteristic
finding with aging. (n = 8) is the number of responses averaged;
vertical calibration is 170 µV for single responses, and 12 µV for
averaged responses; horizontal calibration = 50 ms.
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70 °C until used for these studies. All procedures involving
animals were undertaken in strict compliance with the guidelines of the US Public Health Service’s policy on the Humane
Care and Use of Laboratory Animals, and the ARVO Resolution on the Use of Animals in Ophthalmic and Vision Research.
Genomic DNA and RNA samples: Genomic DNA was
isolated using standard techniques [12] from either blood
samples collected in citrate anticoagulant tubes, or from splenic
samples from deceased dogs. Retina from the enucleated fellow eye of the 10.7-month-old affected dog was utilized for
RNA extraction; total RNA was isolated from retina using the
guanidinium-phenol procedure previously described [13].
Screening of a canine retinal cDNA library for RPE65
clone by polymerase chain reaction (PCR): The canine retinal cDNA library was custom made (Stratagene Cloning Systems, La Jolla, CA) from poly-A+ RNA isolated from retinas
of homozygous normal miniature poodles. RPE65 cDNA sequence was retrieved from the cDNA library by polymerase
chain reaction (PCR) based screening of the library. A forward primer (RPE65-1; 5'-CAA TGC CCT TGT TAA TGT
CTA CCC AG-3') and a reverse primer (RPE65-3; 5'-CCT GCT
TAA TTG TCT CCA AGG TCT C-3') were designed from the
consensus region of human (GenBank accession number
U18991), bovine (GenBank accession numbers L11356 and
X66277) and rat (GenBank accession number AF035673)
RPE65 cDNA sequences. The gene specific forward primer,
RPE65-1, was used in combination with a vector specific reverse primer (pBK-V; 5'-CCG CTC TAG AAG TAC TCT CGA
GTT-3') to amplify the 3'-region of the canine homologue of
RPE65 cDNA. Similarly, the gene specific reverse primer,
RPE65-3, was used in combination with the vector specific
forward primer (pBK-III; 5'-GGT CGA CAC TAG TGG ATC
CAA AG-3') to amplify the 5'-region of the canine RPE65
cDNA that would have an overlapping region with the amplified 3' cDNA fragment. PCR was done for 30 cycles (94 °C
for 1 min, 60 °C for 1 min, 72 °C for 2 min with a final extension at 72 °C for 10 min) using 0.4 µM of each primer pair in
a volume of 50 µl containing 50 mM KCl, 10 mM Tris-HCl
(pH 8.3), 2 mM MgCl2, and 0.2 mM each dATP, dCTP, dGTP
and dTTP.
Reverse transcription (RT)-PCR from canine retina : A
540 nucleotide long 5'-region of canine RPE65 cDNA was
successfully amplified by PCR from the retinal cDNA library,
but the 3'-region of the cDNA did not yield PCR product containing the remainder of the coding sequence. To clone the 3'
end, a new consensus primer (RPE65-8; 5'-TGC TTG CTC
AAC TCA GTG CTT TCT G-3') was designed, as described
above, from the 3'-untranslated region (UTR) of mammalian
RPE65. A 1400 bp DNA fragment was amplified by RT-PCR
using the RPE65-1 and RPE65-8 primer pair from total RNA
isolated from retina using RNA PCR kit (Perkin Elmer, Foster
City, CA). The identity of the amplified DNA fragment was
confirmed to be RPE65 by direct sequencing of the PCR product, and comparison with previously published homologous
sequences using the BLAST service. PCR conditions were as
above.
PCR using genomic DNA templates: To identify the presence of a mutation in the canine RPE65 gene and examine for
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cosegregation of the mutation and the disease, PCR was undertaken for 30 cycles (94 °C for 30 s, 60 °C for 1 min, 72 °C
for 1 min with a final extension at 72 °C for 5 min) using
primers RPE65-1 and RPE65-3 selected from a single exon
(putative exon 5) spanning the location of the mutation. The
sizes of the DNA fragments amplified from homozygous normal and csnb-affected dogs were 109 bp and 105 bp, respectively. The amplified DNA fragments were electrophoresed
in a 6% nondenaturing polyacrylamide gel using TBE buffer
(0.089 M Tris-borate and 0.002 M EDTA, pH 8).
DNA sequencing: PCR amplified DNA fragments were
used directly for sequencing after purification of the samples.
Sequencing was accomplished by Taq cycle sequencing using
BigDye™ fluorescent terminators (PE-Applied Biosystems,
Foster City, CA) in an ABI 377 DNA sequencer (PE-Applied
Biosystems) at the core sequencing facility of Cornell University. Sequence manipulation and comparison were undertaken using programs Seqed (ABI Applied Biosystems, Inc.)
and Gene Jockey II(Biosoft, Cambridge, UK), and the Genbank
BLAST service [14].
RESULTS
Clinical and morphologic characterization of csnb: We have
examined 10 briard dogs affected with csnb that originated
from stock in the US, Canada and France; in addition, we examined five clinically non-affected briards that were related
to the affected dogs in this study. The obligate heterozygous
animals had normal ophthalmic examination; prior studies have
shown that visual function and the ERG of heterozygous ani-

Figure 2. Retinal morphology in csnb. Histologic sections of plastic
embedded retina from a 4.3-month-old dog affected with congenital
stationary night blindness. Sections are taken from the tapetal zone
(T) in the superior quadrant, near the posterior pole (A) or the midperiphery (B). The retina is of normal thickness, and there is a normal number of photoreceptor cells and nuclei in the outer nuclear
layer (ONL). The rod outer segments appear slightly irregular, particularly in the posterior pole (A), but are structurally better preserved
in the mid-periphery (B). The variable shortening of rod inner segments results in outer segments of differing lengths. Cone inner segments appear elongated and distinct (A, B-oblique arrows). Cytoplasmic inclusions are present in the RPE (C-E, arrowheads). These
occur as single small inclusions, or form aggregates or larger inclusions that can be homogeneous or vacuolated. * external limiting
membrane. (A and B x500; C-D x1250).
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mals is normal (Aguirre and Acland, unpublished data). In
contrast, the affected dogs had a severe impairment of visual
function that primarily affected night vision, but, in some cases,
day vision was affected to various degrees. When young, some
of the animals had distinct nystagmus which disappeared with
aging, but could be induced with excitement; no other abnormalities were recognized on clinical ophthalmic exam. The
one older affected dog that was available for examination at 4
years of age also showed no abnormalities on ophthalmologic
examination.
Electroretinography of affected dogs showed that the rod
and cone mediated responses were severely depressed in amplitude in comparison to those recorded from normals (Figure
1). In general, the responses appeared diminutive or non-recordable under most recording conditions, especially when
the retina was stimulated with weak illumination. Higher intensity flickering light stimuli that elicited cone-mediated responses often resulted in low amplitude signals (data not
shown). Signal averaging showed the presence of small amplitude responses that often had a normal waveform, similar
to a “Riggs type” ERG in man [2].
Light microscopic examination of the retinas showed
pathologic changes limited to the retinal pigment epithelium
(RPE) and photoreceptor layers. These abnormalities were
most distinct in plastic embedded sections of the retina of the
younger dog (4.3 months), but were also evident in the eye
from the older affected dog that was embedded in DGD. The
photoreceptor outer segments appeared normal, particularly
in the periphery, but showed slight disorganization in the posterior pole and equator (Figure 2A). Additionally, there was
an uneven shortening of the rod inner segments that caused
the rod outer segments to have a variable length, even when
structurally normal (Figure 2B). The shortening of the rod inner segments resulted in increased prominence of the cones in
the photoreceptor layer. The most remarkable abnormalities,
however, were present in the RPE, and consisted of the accumulation of cytoplasmic inclusions of variable size. These inclusions were single to multiple, and were vacuolated or appeared homogeneous (Figure 2C-E). The RPE inclusions appeared to coalesce and were much larger in the 10.7-monthold dog. The RPE appeared somewhat reactive in that the cells
were slightly hypertrophied, and their apical surfaces were
irregular. At the two ages examined, there were no other pathologic changes in the retina, and no evidence of photoreceptor
degeneration or cell death as indicated by the presence of an
outer nuclear layer of normal thickness.
Characterization of the canine RPE65 cDNA: Overlapping fragments of normal canine RPE65 cDNA were amplified from the retinal cDNA library by PCR, and from retinal
RNA by RT-PCR. The characterized region of normal canine
RPE65 cDNA spans 1724 nucleotides (GenBank accession
number AF084537), and includes 1602 nucleotides of coding
sequence predicted to encode a protein of 533 amino acids
(61 kDa), 27 nucleotides of 5'-UTR and 94 nucleotides of 3'UTR (Figure 3). Over the coding region, the canine RPE65
gene shares 88-89% nucleotide sequence identity with homologous human and bovine sequences, and 83% identity with rat
sequence. The deduced amino acid sequence shares 98%, 97%,
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and 93% identity with homologous human, bovine, and rat sequences, respectively.
csnb results from the same mutation in the RPE65 gene causing retinal dystrophy
in Swedish briard dogs: Once we characterized the normal canine RPE65 cDNA, the
cDNA was amplified from csnb-affected retinal RNA and compared with the normal.
We observed that the four nucleotide (AAGA) deletion reported to cause retinal dys(A)
1
28
88
148
208
268
328
388
448
508
568
628
688
748
808
868
928
988
1048
1108
1168
1228
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cgaccgtctgtcctgccctgggagaca
Met Ser Ile Gln Val Glu His Pro Ala Gly Gly Tyr Lys Lys Leu Phe Glu Thr Val Glu
ATG TCC ATC CAA GTG GAG CAT CCC GCC GGC GGT TAC AAG AAG CTG TTT GAA ACC GTG GAA
Glu Leu Ser Ser Pro Leu Thr Ala His Val Thr Gly Arg Ile Pro Leu Trp Leu Thr Gly
GAG CTG TCG TCG CCG CTC ACC GCC CAC GTG ACA GGC AGG ATC CCG CTC TGG CTC ACG GGC
Ser Leu Leu Arg Cys Gly Pro Gly Leu Phe Glu Val Gly Ser Glu Pro Phe Tyr His Leu
AGT CTC CTC CGA TGC GGA CCG GGG CTC TTC GAG GTT GGA TCT GAA CCA TTT TAC CAC CTG
Phe Asp Gly Gln Ala Leu Leu His Lys Phe Asp Phe Lys Glu Gly His Val Thr Tyr His
TTT GAC GGA CAA GCC CTT CTG CAC AAG TTC GAC TTT AAA GAA GGA CAC GTC ACC TAT CAC
Arg Arg Phe Ile Arg Thr Asp Ala Tyr Val Arg Ala Met Thr Glu Lys Arg Ile Val Ile
AGA AGG TTC ATC CGC ACC GAT GCT TAC GTC CGG GCA ATG ACC GAG AAA AGG ATC GTC ATA
Thr Glu Phe Gly Thr Cys Ala Phe Pro Asp Pro Cys Lys Asn Ile Phe Ser Arg Phe Phe
ACG GAA TTT GGC ACC TGT GCG TTC CCA GAT CCC TGC AAG AAT ATA TTT TCC AGG TTT TTT
Ser Tyr Phe Arg Gly Val Glu Val Thr Asp Asn Ala Leu Val Asn Val Tyr Pro Val Gly
TCT TAC TTC CGA GGA GTG GAG GTC ACT GAC AAT GCC CTT GTT AAC GTC TAC CCA GTA GGG
Glu Asp Tyr Tyr Ala Cys Thr Glu Thr Asn Phe Ile Thr Lys Ile Asn Pro Glu Thr Leu
GAA GAT TAC TAC GCC TGC ACG GAG ACC AAC TTC ATT ACA AAG ATT AAT CCT GAG ACC CTG
Glu Thr Ile Lys Gln Val Asp Leu Cys Asn Tyr Val Ser Val Asn Gly Ala Thr Ala His
GAG ACA ATT AAG CAG GTT GAT CTC TGC AAC TAC GTC TCT GTC AAT GGA GCC ACC GCT CAC
Pro His Ile Glu Asn Asp Gly Thr Val Tyr Asn Ile Gly Asn Cys Phe Gly Lys Asn Phe
CCC CAC ATT GAA AAT GAT GGG ACT GTT TAC AAC ATT GGT AAT TGC TTT GGG AAA AAT TTT
Ser Ile Ala Tyr Asn Ile Val Lys Ile Pro Pro Leu Gln Ala Asp Lys Glu Asp Pro Ile
TCG ATT GCC TAC AAT ATT GTA AAG ATC CCT CCA CTC CAA GCA GAC AAG GAA GAT CCA ATA
Ser Lys Ser Glu Val Val Val Gln Phe Pro Cys Ser Asp Arg Phe Lys Pro Ser Tyr Val
AGC AAG TCC GAG GTC GTC GTA CAA TTC CCC TGC AGC GAC CGA TTC AAG CCA TCG TAC GTC
His Ser Phe Gly Leu Thr Pro Asn Tyr Ile Val Phe Val Glu Thr Pro Val Lys Ile Asn
CAT AGT TTT GGT TTG ACT CCC AAC TAT ATT GTT TTT GTG GAG ACG CCA GTC AAA ATT AAC
Leu Leu Lys Phe Leu Ser Ser Trp Ser Leu Trp Gly Ala Asn Tyr Met Asp Cys Phe Glu
CTG CTC AAG TTC CTT TCT TCG TGG AGT CTT TGG GGA GCC AAC TAC ATG GAT TGT TTT GAG
Ser Asn Glu Thr Met Gly Val Trp Leu His Ile Ala Asp Lys Lys Arg Lys Lys Tyr Leu
TCC AAT GAA ACC ATG GGG GTT TGG CTT CAC ATC GCT GAC AAA AAA AGA AAA AAG TAT CTC
Asn Asn Lys Tyr Arg Thr Ser Ser Phe Asn Leu Phe His His Ile Asn Thr Tyr Glu Asp
AAT AAT AAG TAC AGG ACC TCT TCC TTT AAT CTC TTC CAT CAT ATC AAT ACT TAC GAA GAC
Asn Glu Phe Leu Ile Val Asp Leu Cys Cys Trp Lys Gly Phe Glu Phe Val Tyr Asn Tyr
AAT GAG TTT CTG ATT GTG GAT CTC TGC TGC TGG AAA GGA TTT GAA TTC GTC TAC AAT TAC
Leu Tyr Leu Ala Asn Leu Arg Glu Asn Trp Glu Glu Val Lys Lys Asn Ala Arg Lys Ala
TTG TAT TTA GCC AAT TTA CGT GAG AAC TGG GAA GAG GTG AAA AAA AAT GCC AGA AAG GCT
Pro Gln Pro Glu Val Arg Arg Ser Val Leu Pro Leu Asn Ile Asp Lys Ala Asp Thr Gly
CCG CAG CCT GAA GTT AGG AGA TCC GTG CTT CCT TTG AAT ATC GAC AAG GCC GAC ACA GGC
Lys Asn Leu Val Thr Leu Pro Asn Thr Thr Ala Thr Ala Thr Leu Arg Ser Asp Glu Thr
AAG AAC CTA GTC ACC CTT CCC AAC ACG ACG GCC ACT GCA ACT CTG CGC AGC GAC GAG ACC
Ile Trp Leu Glu Pro Glu Val Leu Phe Ser Gly Pro Arg Gln Ala Phe Glu Phe Pro Gln
ATC TGG CTG GAA CCT GAG GTT CTC TTC TCA GGG CCT CGT CAA GCC TTT GAG TTT CCT CAA
Ile Asn Tyr Gln Lys Tyr Gly Gly Lys Pro Tyr Thr Tyr Ala Tyr Gly Leu Gly Leu Asn
ATC AAC TAT CAG AAG TAT GGC GGG AAG CCT TAC ACG TAC GCG TAT GGA CTT GGC TTG AAT
His Phe Val Pro Asp Arg Leu Cys Lys Leu Asn Val Lys Thr Lys Glu Thr Trp Val Trp
CAC TTC GTT CCG GAC AGG CTC TGC AAG CTG AAC GTC AAG ACT AAA GAA ACG TGG GTA TGG
Gln Glu Pro Asp Ser Tyr Pro Ser Glu Pro Ile Phe Val Ser His Pro Asp Ala Leu Glu
CAA GAG CCC GAC TCA TAC CCA TCA GAA CCC ATC TTT GTT TCT CAC CCA GAT GCC TTG GAA
Glu Asp Asp Gly Val Val Leu Ser Val Val Val Ser Pro Gly Ala Gly Gln Lys Pro Ala
GAA GAT GAT GGT GTA GTT CTG AGT GTG GTG GTG AGC CCT GGG GCA GGA CAA AAG CCT GCT
Tyr Leu Leu Ile Leu Asn Ala Lys Asp Leu Ser Glu Val Ala Arg Ala Glu Val Glu Ile
TAT CTT CTG ATT CTG AAT GCC AAG GAT TTG AGT GAA GTT GCC AGG GCT GAA GTG GAG ATT
Asn Ile Pro Val Thr Phe His Gly Leu Phe Lys Lys Ser *
AAC ATC CCT GTC ACC TTT CAT GGA CTG TTC AAA AAA TCC TAA gtacattctagcaaattatattt
ctattgacaaagtcaagaaaaagtgaggtctgcaatcaaattctgttcaattttagcctgctgtattacagg
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Figure 3. Canine RPE65, normal (wildtype) and csnb-mutant sequence. (A) Nucleotide (cDNA)
and deduced amino acid sequences of canine RPE65 (wildtype allele). Nucleotides 487-490
(AAGA), shown in green, is the sequence deleted in the mutant allele. Nucleotides 417-442,
and 523-499, shown in blue, are binding sites for primers RPE65-1 (forward) and RPE65-3
(reverse), respectively, used to amplify across the mutant site. The amino acids that differ from
human sequence (codons 225, 262, 308, 322, 368, 395, 397, and 427) are shown in red. The
“Start” (Met) and “Stop” (*) codons, nucleotides 28-30 and 1627-9, respectively, are shown in
purple. The 5' and 3' UTRs (nucleotides 1-27 and 1630-1725, respectively) are shown with
lower case letters. (B) Deduced amino acid sequence of canine mutant RPE65. Amino acids
that differ from wildtype sequence are shown in red.

trophy in Swedish briards [6] is present
in csnb-affected briards in USA and
Canada. The deleted nucleotides
(AAGA) represent nucleotides 487-490
of wildtype canine RPE65 sequence,
and correspond to nucleotides 340-343
of human exon 5 (Genbank accession
number U20479). The mutation produces a frameshift, causing a deduced
mistranslation of (now) nucleotides 487
through 645, with a stop at (now) codon
205 (nucleotides 643-645 of mutant sequence). No other disease causing mutations were identified in the sequence
obtained from the affected dogs.
To identify the mutation from genomic DNA in suspected dogs, a region
of putative exon 5 encompassing the
site of the mutation was amplified. As
shown in Figure 4, PCR using genomic
DNA from csnb-affected and normal
briard dogs resulted in amplification of
DNA fragments 105 bp and 109 bp
long, respectively. As expected, PCR
product from an obligate heterozygote
dog contained both the alleles. Also, the
presence of two distinct heteroduplex
bands with slower mobility in the polyacrylamide gel is a typical observation
associated with PCR products of heterozygous samples containing two alleles resulting from a short insertion or
deletion. To determine if the mutation
identified in csnb-affected dogs is the
same as the one described for Swedish
dogs with retinal dystrophy, two affected and two heterozygous dogs were
analyzed, and the results were identical to the observation made for csnb
alleles in US and Canadian briard dogs
(Figure 4). Sequencing of the amplified
DNA fragments from the normal and
csnb-affected briard revealed deletion
of four nucleotides (AAGA).
Cosegregation of the RPE65 mutation in csnb-affected briard pedigree:
Once the four nucleotide deletion in the
RPE65 gene was identified in
csnbaffected dogs, we examined a briard pedigree informative for csnb to
determine if the mutation cosegregated
with the disease. In the animals available for molecular testing, we found
complete cosegregation of the mutation
with the disease; affected dogs were
homozygous for the four nucleotide
deletion while obligate carriers were
heterozygous for the normal and mu-
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tant alleles. In this small pedigree, it was possible to readily
differentiate the homozygous normal from heterozygous
samples from phenotypically normal animals that were either
genetically normal or carriers (Figure 5).
Progressive retinal atrophy (PRA) in the briard dogs is
not associated with the RPE65 mutation causing csnb and
retinal dystrophy: To determine if this mutation in the RPE65
gene is associated with PRA in the briard, we tested samples
from four littermate dogs of this breed in which a diagnosis of
PRA had been made in one of them on the basis of the characteristic visual, ophthalmoscopic and ERG abnormalities. We
found no abnormality in the region of the RPE65 gene that
harbors the mutation responsible for csnb, either in the PRAaffected dog or in its normal littermates (Figure 4, right panel).
DISCUSSION
The clinical, electrophysiologic and pathologic features of
retinal dystrophy in the briard dog have been reported in a
series of very detailed studies from Sweden [1-5]. The disease
has a characteristic clinical phenotype, consisting of profound
visual impairment present soon after the dog is sufficiently
mature to test visual function (5-6 weeks of age), and a normal appearing fundus, at least for the first 3-4 years of age.
Older dogs may show subtle retinal abnormalities indicative
of a slowly progressive retinal degenerative process. The ERG
responses, both rod and cone mediated, are also abnormal,
and the DC ERG suggests a defect in the phototransduction
process [5]. Surprisingly, the photoreceptor cells do not show
extensive pathologic abnormalities, at least in the early stages
of the disease, that would be expected for animals with such
functional deficits. The RPE has shown a dramatic accumulation of lipoidal inclusions [3,15] that, until now, appeared to

Figure 4. Amplification of canine RPE65 gene fragment from briard
dogs. Amplification of putative exon 5 of RPE65 gene from briard
dogs affected with csnb, retinal dystrophy (Ret. Dyst.) and progressive retinal atrophy (PRA). A small region of exon 5 was amplified
by PCR from (a) csnb-affected (lanes 1-3), carrier (lane 4), and normal (lane 5) dogs of US and Canadian origin; (b) Swedish briard
dogs affected with retinal dystrophy (lanes 6 and 7) or carrier for the
disease (lane 8); and (c) PRA-affected (lane 9) and nonaffected littermate (lane 10) briard dogs of US origin. The PCR products were
separated in 6% non denaturing polyacrylamide gel. The sizes of the
amplified DNA fragments from the two alleles, and the relative location of the heteroduplexes formed between these two alleles in the
gel are indicated. The marker lane (M) contains 100 bp DNA ladder.
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be an unexplained byproduct of the disease process (see below).
Because of the clinical similarities in phenotype between
retinal dystrophy and csnb, a disease identified in briard dogs
from the United States and Canada, we examined a selected
population of briards using methods which would evaluate
the clinical, functional and morphologic characteristics of csnb
in a manner that was analogous to the studies done on the
Swedish dogs. With the limitation imposed by using slightly
different methods, our results are totally compatible to those
published by Narfström and associates in their studies [1,2,4].
At least on a clinical and morphologic basis, we can conclude
that csnb and retinal dystrophy appear to represent the same
disorder. Based on the four nucleotide deletion in the RPE65
gene that was reported to be causally associated with retinal
dystrophy in briards [6], we cloned and characterized the canine RPE65 cDNA to determine if a mutation in this gene is
present in csnb, and if it is the same as that causing retinal
dystrophy in the Swedish dogs.
Previous reports have indicated that the RPE65 gene is
exclusively expressed in the RPE [16,17]. However, we decided to characterize the cDNA from a retinal cDNA library
on the premise that even a low level of expression of the gene
in the tissue would be sufficient for amplification of the coding sequence, and characterization of the UTR. The characterized region of normal canine RPE65 cDNA spans 1724 nucleotides (GenBank accession number AF084537), and includes
1602 nucleotides of coding sequence predicted to encode a
protein of 533 amino acids (61 kDa), 27 nucleotides of 5'UTR and 94 nucleotides of 3'-UTR. Comparison of the sequence between the normal and csnb-affected dog indicated
that in the affected there was a four nucleotide deletion
(AAGA) in the putative exon 5 of the RPE65 gene that was
the same as described by Gal and associates for dogs with
retinal dystrophy. The deleted nucleotides (AAGA), represent
nucleotides 487-490 of wildtype canine RPE65 sequence, and
correspond to nucleotides 340-343 of human exon 5. The
mutation produces a frameshift, causing a deduced mistranslation with a stop at (now) codon 205 (nucleotides 643-645 of
the mutant sequence), and a presumably non-functional RPE65
gene product.
To establish if the observed mutation was causally associated with the disease, we amplified from genomic DNA a
region of the putative exon 5 encompassing the site of the
mutation. In a three generation pedigree informative for csnb,
we could establish the cosegregation of the mutant allele with
100% concordance. These dogs were part of a larger sample
of 15 briard dogs whose disease status was known, and derived from breeding stock that originated from the US and
France. In all cases, affected dogs showed the homozygous
four nucleotide deletion of the RPE65 gene, while obligate
heterozygous dogs had the mutation in only one allele. Lastly,
we tested four Swedish briard or briard-beagle crosses, two
affected and two heterozygous for retinal dystrophy [1], and
found the same mutation. Identification of the same mutation
in briards with csnband retinal dystrophy confirms the molecular identity of the two disorders. Furthermore, because
some of the dogs tested in this study were apparently unre-
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lated, the finding of a common mutation in dogs derived from
different countries suggests a founder effect causing the propagation of a common mutant allele in the population at risk.
Progressive retinal atrophy also is present sporadically in
the briard breed, and the clinical and functional abnormalities
identified in the intermediate stages of the disease could be
compatible with those present in older dogs affected with csnb.
To exclude the four nucleotide deletion in the RPE65 gene
from causal association with PRA, we tested samples from
four littermate briard dogs, one PRA-affected and three nonaffected. For the region of the RPE65 gene examined by PCR,
we did not find the four nucleotide deletion that results in csnb.
Thus, this mutation could be excluded as a cause of PRA in
this dog breed.
In their 1997 paper, Gu and associates described five different mutations in the RPE65 gene responsible for autosomal recessive childhood-onset severe retinal dystrophy [18].
Most patients had severe visual deficits present at birth or
within the first decade of life. Ophthalmoscopic abnormalities varied from vascular attenuation and optic disc atrophy
without bone spicules, to lesions typical of advanced retinitis
pigmentosa in adults. In these patients, the disease progresses
to severe visual impairment and blindness, and concomitant
ophthalmoscopic abnormalities indicative of advanced retinal degeneration [18]. Similar abnormalities have been described in a second study of the disease [19]. More recently,
mutations in this gene have been causally associated with autosomal recessive RP or Leber congenital amaurosis [20]. Al-

Figure 5. Cosegregation of RPE65 gene with csnb in briard dogs.
Mendelian inheritance of the RPE65 mutation in a briard pedigree
informative for csnb. Affected dogs are represented by black squares
(males) and circles (females); obligate heterozygous and clinically
non-affected dogs are represented by half filled and open symbols,
respectively. The region of RPE65 exon 5 containing the mutation
was amplified from genomic DNA of individual dogs, and the PCR
products were separated in a 6% non denaturing polyacrylamide gel.
Each lane in the illustration shows PCR product obtained from DNA
samples of the dog corresponding to the lane. Some of the dogs of
the pedigree from which the DNA samples were not available do not
correspond to any marked lane of the gel. PCR products from the
affected dogs (lanes 2, 6, and 8) contain only the smaller DNA fragment (105 bp) due to the presence of a four nucleotide deletion. Homozygous normal dogs (lanes 4 and 7) contain the normal allele,
hence the larger DNA fragment (109 bp). As expected, PCR products from the obligate heterozygotes (lanes 1, 3, and 5) contain both
of the DNA fragments, and the heteroduplexes formed between the
complementary strands of the two alleles.
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though the profound visual deficit early in life is similar in the
human and dog, the lack of ophthalmoscopically visible advanced retinal degeneration in adult dogs is not, and may indicate a difference in the temporal course of the photoreceptor disease. After all, most dogs affected with the different
forms of PRA show evidence of advanced fundus pathology
by 5 years [7], an age that would be comparable to a 35-yearold human.
Mice with an RPE65 gene knockout were recently created [21]. Homozygous mutant mice show irregularities of
the rod outer segments by 15 weeks of age, and these changes
are associated with a 4.5 log unit increase in the dark adapted
threshold, and a small amplitude ERG that is almost identical
to that recorded under light adapted conditions. Even though
the rod ERG is abolished, the results indicate that the cone
ERG is normal (Redmond TM, Personal Communication, May,
1998). A recent commentary has suggested that the RPE65
gene product functions in retinoid metabolism in the RPE and
retina [22]. Based on this putative function, the normal cone
ERG function in the absence of rod mediated activity could
be interpreted as supporting the hypothesis that rod and cones
have different and independent pathways for visual pigment
regeneration [23]. This difference, however, does not appear
to exist in the dog since cone ERG function was compromised
in all dogs with the mutation, and profound impairment of
day vision was present in some of the affected animals. This
issue merits further investigation as it may play a significant
role in the evaluation of mice or dogs following RPE cell transplantation or vector-mediated gene therapy for the experimental treatment of the disease.
The salient pathologic abnormality in the retina of dogs
with the four nucleotide deletion in the RPE65 gene, documented in this study or reported previously [3,15], is the accumulation of lipoidal inclusions of variable size within the
pigment epithelium. Mice with the RPE65 gene knockout have
no rhodopsin in the dark adapted retinal rods, but accumulate
all-trans retinyl esters in the pigment epithelium (Redmond
TM, Personal Communication, May, 1998). The accumulation of all-trans retinyl esters in the RPE suggests that the
RPE65 protein functions in one of the metabolic steps involved
in the conversion of all-trans retinyl esters to 11-cis retinol
[22]. Although the precise function of the RPE65 protein in
RPE retinoid metabolism is still to be determined, deficiency
of the protein, either in naturally occurring cases or in
transgenic knockout mice, results in the accumulation of alltrans retinyl esters in the RPE. Based on prior studies of vitamin A metabolism in the frog eye, these retinyl esters probably accumulate in oil droplets within the RPE which is the
major storage depot for esterified vitamin A in the RPE [24].
These lipoidal inclusions are present in the RPE of affected
dogs, and their number and size increases with age as reported
here and in other studies [3,15].
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The typographical corrections below were made to the article on the date noted. These changes have been incorporated in the article and the
details are documented here.
17 November 1998: In the caption of Figure 3A, the word "gray" was changed to "purple" and the color of the gray text was changed to
purple.

